## **Core Concept**
Gynecomastia refers to the enlargement of breast tissue in males, often caused by an imbalance between estrogen and androgen levels. This condition can result from various factors, including hormonal imbalances, certain medications, and underlying medical conditions.

## **Why the Correct Answer is Right**
The correct answer, **C.**, is associated with **Spironolactone**. Spironolactone is a potassium-sparing diuretic that acts as an antagonist to aldosterone receptors. It also has anti-androgenic effects, which can lead to an imbalance in the estrogen-to-androgen ratio, promoting the development of gynecomastia.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while certain conditions can lead to gynecomastia, the specific association with **A.** is not provided, making it an unclear choice.
- **Option B:** This option is incorrect as there's no direct association provided with **B.**, and without context, it's hard to assess its relevance to gynecomastia.
- **Option D:** This option is incorrect because, similar to **A.** and **B.**, the specific association with **D.** is not provided, and without further context, it cannot be accurately evaluated.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that drugs which affect the hormonal balance, such as spironolactone (an anti-androgen), can cause gynecomastia. This is a critical consideration in pharmacological management, especially in long-term treatments.

## **Correct Answer:** . **Spironolactone**